These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19533138)

  • 1. Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever.
    Uyanik A; Albayrak F; Uyanik MH; Dursun H; Keles M; Cetinkaya R
    Rheumatol Int; 2010 Feb; 30(4):467-71. PubMed ID: 19533138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever.
    Karatay S; Yildirim K; Erdal A; Uzkeser H; Erdem FH; Yanmaz V
    J Back Musculoskelet Rehabil; 2010; 23(1):21-3. PubMed ID: 20231785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever.
    Ceri M; Unverdi S; Altay M; Ureten K; Oztürk MA; Gönen N; Duranay M
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S58-61. PubMed ID: 20868572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CCP Antibodies Are Not Associated with Familial Mediterranean Fever in Childhood.
    Onur H; Aral H; Arica V; Bercem G; Usta M; Kasapcopur O
    Int J Rheumatol; 2013; 2013():498581. PubMed ID: 24106502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
    Mouterde G; Lukas C; Goupille P; Flipo RM; Rincheval N; Daurès JP; Combe B
    J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
    Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
    Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
    Wielosz E; Majdan M; Dryglewska M; Zwolak R
    Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM; Phillips R; Hagan EM; Chibnik LB; Costenbader KH; Schur PH
    Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
    Serdaroğlu M; Cakirbay H; Değer O; Cengiz S; Kul S
    Rheumatol Int; 2008 Aug; 28(10):965-70. PubMed ID: 18418600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
    Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
    Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
    Qu SJ; Ye H; Jia RL; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.
    Bøyesen P; Hoff M; Odegård S; Haugeberg G; Syversen SW; Gaarder PI; Okkenhaug C; Kvien TK
    Arthritis Res Ther; 2009; 11(4):R103. PubMed ID: 19570223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.